MARKET

OBIO

OBIO

Orchestra BioMed Holdings Inc
NASDAQ
4.260
-0.230
-5.12%
After Hours: 4.086 -0.174 -4.08% 17:15 03/27 EDT
OPEN
4.435
PREV CLOSE
4.490
HIGH
4.460
LOW
4.180
VOLUME
137.07K
TURNOVER
--
52 WEEK HIGH
5.42
52 WEEK LOW
2.200
MARKET CAP
249.30M
P/E (TTM)
-3.8410
1D
5D
1M
3M
1Y
5Y
1D
Orchestra BioMed publishes AVIM Therapy presentation on hypertension and diastolic heart failure
Reuters · 4d ago
Orchestra BioMed Publishes CRT 2026 AVIM Therapy Presentation
Reuters · 4d ago
Weekly Report: what happened at OBIO last week (0316-0320)?
Weekly Report · 5d ago
Analysts’ Top Healthcare Picks: Orchestra BioMed Holdings (OBIO), Cardinal Health (CAH)
TipRanks · 03/18 07:40
Top Executive Makes Bold Insider Move at Orchestra BioMed
TipRanks · 03/17 02:02
Orchestra BioMed CEO and Chairperson David P. Hochman acquires USD 42,900 in common shares
Reuters · 03/16 20:55
Orchestra BioMed: Accelerating Pivotal Trials and Strengthened Liquidity Support Buy Rating and Long‑Term Growth Outlook
TipRanks · 03/16 10:26
Weekly Report: what happened at OBIO last week (0309-0313)?
Weekly Report · 03/16 09:22
More
About OBIO
Orchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.

Webull offers Orchestra Biomed Holdings Inc stock information, including NASDAQ: OBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OBIO stock methods without spending real money on the virtual paper trading platform.